Antipyretic, analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat.
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001831:Body Temperature / Q000187:drug effects; D002188:Cannabis / Q000627:therapeutic use*; D002351:Carrageenan; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000494:pharmacology / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D006941:Hyperesthesia / Q000139:chemically induced / Q000188:drug therapy; D008297:Male; D010653:Phenylbutazone / Q000627:therapeutic use; D008517:Phytotherapy; D051381:Rats; D013997:Time Factors; D015003:Yeasts
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D013759:Dronabinol; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin